Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Kinex Pharma of the US Receives Investment from Hong Kong Investor

publication date: Aug 1, 2012
Kinex Pharmaceuticals, a New York-state startup, received a “substantial” investment from Dr. Manson Fok, who is the Founder of the Pedder Clinic, one of the largest private medical practices in Hong Kong. Dr. Fok will serve as an advisor to Kinex on its China strategy. Kinex has developed a proprietary platform to discover new molecules for cancer and immune-modulatory diseases. So far, Kinex has licensed China rights for two prospective cancer drugs to China companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital